Form 4: Hims & Hers Director Kare Schultz Acquires Shares Through RSU Vesting

Hims & Hers Health, Inc. Director Kare Schultz acquired 9,118 shares of Class A Common Stock on June 12, 2025, through the vesting of Restricted Stock Units.

Summary

• Kare Schultz, a Director of Hims & Hers Health, Inc. (HIMS), acquired 9,118 shares of Class A Common Stock.
• The acquisition occurred on June 12, 2025, as reported in the SEC Form 4 filing.
• These shares were obtained through the vesting of Restricted Stock Units (RSUs), which represent a contingent right to receive one share of Class A Common Stock for each RSU.
• The RSUs vested subject to continuous service, on the earlier of the date of the 2025 annual meeting of stockholders or June 15, 2025.

Sentiment

Score: 7

Explanation: The filing reports a routine vesting of Restricted Stock Units for a director, which increases their direct ownership in the company, generally viewed as a positive alignment of interests. It is a standard, expected event.

Positives

• Director Kare Schultz increased their direct beneficial ownership of Hims & Hers Health, Inc. Class A Common Stock by 9,118 shares.
• The acquisition through RSU vesting aligns the director's interests with those of the company's shareholders.

Negatives

• No direct negatives are indicated in this standard insider transaction filing.

Risks

• No specific risks are detailed in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• This Form 4 filing does not include direct management comments or quotes, as it is a regulatory report of an insider transaction.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Comparison to Industry Standards

• This Form 4 filing reports a specific insider transaction (RSU vesting) and does not offer a basis for comparison to industry-wide compensation standards or specific company benchmarks.

Related Party Transactions

• No specific related party transactions beyond the standard equity compensation (RSU vesting) for a director are detailed in this filing.

Stakeholder Impact

• Shareholders: Increased director ownership may signal confidence in the company's future and better alignment of interests between management and shareholders.

Next Steps

• The 2025 annual meeting of stockholders is a key event related to the RSU vesting conditions, as the vesting was tied to the earlier of this meeting or June 15, 2025.

Key Dates

Keywords

Hims & Hers Health, HIMS, Kare Schultz, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Director Share Acquisition, Equity Compensation